Zhaoheng Liu
Overview
Explore the profile of Zhaoheng Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
11
Citations
23
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peng Y, Costello C, Liu Z, Kumar A, Gu Z, Kosuru N, et al.
Biosci Trends
. 2025 Mar;
PMID: 40024684
Dermatologic toxicities associated with targeted therapies may impact drug intolerance and predict drug response, among which rash is most frequently reported and well delineated. However, the profile and effect of...
2.
Bui T, Vu V, Liu Z, Thomas M
J Vib Control
. 2024 Nov;
30(21-22):4852-4867.
PMID: 39493533
This paper proposes a novel method for the modal analysis of slow-varying vibration structures based on vector autoregressive models. The basic idea of this method consists of using a short-time...
3.
Wang Y, Cheng S, Zhang H, Zhang Y, Ding C, Peng T, et al.
Recent Pat Anticancer Drug Discov
. 2023 Sep;
19(3):308-315.
PMID: 37723963
Background: Gefitinib, an Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR-TKI), frequently causes side effects when used to treat non-small cell lung cancer. Objective: The purpose of this experiment was...
4.
Cao F, Liu Z, Hao Q, Zhao R, Bao L, Cui X, et al.
Can J Infect Dis Med Microbiol
. 2022 Oct;
2022:7609550.
PMID: 36193093
Coronavirus disease 2019 (COVID-19), which causes severe respiratory illness, was first reported in Wuhan, China. The etiology of the disease is a new novel coronavirus named severe acute respiratory syndrome...
5.
Liu H, Pang Q, Cao F, Liu Z, Wei W, Li Z, et al.
Front Pharmacol
. 2022 Jul;
13:921209.
PMID: 35903328
Number 2 Feibi Recipe (N2FBR) is a traditional Chinese medicine formula for treating idiopathic pulmonary fibrosis. N2FBR inhibits HO-mediated oxidative stress damage in alveolar epithelial cells by increasing autophagy, as...
6.
Tan Y, Wang X, Zhang J, Zhang H, Li H, Peng T, et al.
Front Pharmacol
. 2022 May;
13:850175.
PMID: 35586051
Alzheimer's disease (AD) is the most common cause of dementia. The emerging data suggest that cognitive decline occurred in the setting of A accumulation with synaptic dysfunction, which started to...
7.
Wang Y, Zhang Y, Ding C, Jia C, Zhang H, Peng T, et al.
Front Oncol
. 2022 Apr;
12:790713.
PMID: 35372072
Background: Adverse skin reactions are the most common side effects of epidermal growth factor receptor inhibitors (EGFRIs) in the treatment of cancer, significantly affecting the survival rate and quality of...
8.
Wei W, Li G, Liu Z, Yang H, Liu S, Zou X, et al.
Exp Ther Med
. 2022 Jan;
23(1):110.
PMID: 34976152
Feibi decoction (FBD) is a traditional Chinese herbal medicine and has been clinically used in the treatment of pulmonary fibrosis (PF), which is characterized by diffuse interstitial inflammation and exaggerated...
9.
Tan Y, Zhang J, Yang K, Xu Z, Zhang H, Chen W, et al.
J Alzheimers Dis
. 2021 Nov;
85(1):261-272.
PMID: 34776438
Background: Chinese Herbal Medicines (CHMs), as an important and integral part of a larger system of medicine practiced in China, called Traditional Chinese Medicine (TCM), have been used in stroke...
10.
Wang W, Liu Z, Niu J, Yang H, Long Q, Liu H, et al.
Evid Based Complement Alternat Med
. 2020 Oct;
2020:5814658.
PMID: 33101446
Fibrotic remodeling has become the result of many lung diseases, and these disorders can be categorized with known as well as unknown etiologies. Idiopathic pulmonary fibrosis is the most fatal...